Everything you posted there is a lie
1. Company has 4.7 million in funding
2. Company has 2 million in R&D coming in
3. AGN phase 1 costed 3.5 million dollars
They have 7 million in cash and from Feb announcement of cap raise their funding takes them all the way to phase 2 and non dilutive funding. Market cap right now is 6 million. I have reported you to the company for misinformation
Ann: Brain Injury Program GLP Studies Further Update, page-13
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.05M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.5¢ | $20.26K | 185.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1234942 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 131271 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| NYR (ASX) Chart |